Reid BJ, Li X, Galipeau PC, Vaughan TL. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nature reviews Cancer. 2010;10(2):87-101. Epub 2010/01/23. doi: 10.1038/nrc2773. PubMed PMID: 20094044; PubMed Central PMCID: PMC2879265.
Kusano C, Gotoda T, Khor CJ, Katai H, Kato H, Taniguchi H, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. Journal of gastroenterology and hepatology. 2008;23(11):1662-5. Epub 2009/01/06. doi: 10.1111/j.1440-1746.2008.05572.x. PubMed PMID: 19120859.
Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nature genetics. 1999;22(1):106-9. Epub 1999/05/13. doi: 10.1038/8816. PubMed PMID: 10319873; PubMed Central PMCID: PMC1559997.
Stachler MD, Taylor-Weiner A, Peng S, McKenna A, Agoston AT, Odze RD, et al. Paired exome analysis of Barrett's esophagus and adenocarcinoma. Nature genetics. 2015. Epub 2015/07/21. doi: 10.1038/ng.3343. PubMed PMID: 26192918.
Dulak AM, Schumacher SE, van Lieshout J, Imamura Y, Fox C, Shim B, et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer research. 2012;72(17):4383-93. Epub 2012/07/04. doi: 10.1158/0008-5472.CAN-11-3893. PubMed PMID: 22751462; PubMed Central PMCID: PMC3432726.